144 related articles for article (PubMed ID: 15951416)
1. Safety of serial monthly administration of triple-dose gadopentetate dimeglumine in multiple sclerosis patients: preliminary results of the BECOME trial.
Wolansky LJ; Haghighi MH; Sevdalis E; Cook SD; Sethi N; Liu J; Joseph G; Tulloch K; Cadavid D
J Neuroimaging; 2005 Jul; 15(3):289-90. PubMed ID: 15951416
[No Abstract] [Full Text] [Related]
2. Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial.
Minagar A; Alexander JS; Schwendimann RN; Kelley RE; Gonzalez-Toledo E; Jimenez JJ; Mauro L; Jy W; Smith SJ
Arch Neurol; 2008 Feb; 65(2):199-204. PubMed ID: 18071030
[TBL] [Abstract][Full Text] [Related]
3. Hypophosphatemia is Associated with the Serial Administration of Triple-Dose Gadolinium to Patients for Brain MRI.
Wolansky LJ; Cadavid D; Punia V; Kim S; Cheriyan J; Haghighi M; Cook SD
J Neuroimaging; 2015; 25(3):379-83. PubMed ID: 25867798
[TBL] [Abstract][Full Text] [Related]
4. Ibuprofen does not suppress active multiple sclerosis lesions on gadolinium-enhanced MR images.
Barkhof F; van Waesberghe JH; Uitdehaag BM; Polman CH
Ann Neurol; 1997 Dec; 42(6):982. PubMed ID: 9403493
[No Abstract] [Full Text] [Related]
5. Effects of interferon beta-1b on black holes in multiple sclerosis over a 6-year period with monthly evaluations.
Bagnato F; Gupta S; Richert ND; Stone RD; Ohayon JM; Frank JA; McFarland HF
Arch Neurol; 2005 Nov; 62(11):1684-8. PubMed ID: 16157739
[TBL] [Abstract][Full Text] [Related]
6. Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis.
Schwid SR; Panitch HS
Clin Ther; 2007 Sep; 29(9):2031-48. PubMed ID: 18035202
[TBL] [Abstract][Full Text] [Related]
7. Can gadopentetate dimeglumine be safely administered more rapidly than the FDA-approved injection rate for liver imaging?
Shiehmorteza M; Hanna RF; Middleton MS
AJR Am J Roentgenol; 2007 Oct; 189(4):W231. PubMed ID: 17885038
[No Abstract] [Full Text] [Related]
8. [Interferon beta-1b in multiple sclerosis--news regarding open questions].
Nervenarzt; 1997 Aug; 68(8 Suppl Interferon):1-4. PubMed ID: 9380220
[No Abstract] [Full Text] [Related]
9. Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use.
Knopp MV; Balzer T; Esser M; Kashanian FK; Paul P; Niendorf HP
Invest Radiol; 2006 Jun; 41(6):491-9. PubMed ID: 16763467
[TBL] [Abstract][Full Text] [Related]
10. An exploratory study on interferon beta dose effect in reducing size of enhancing lesions in multiple sclerosis.
Di Rezze S; Gupta S; Durastanti V; Millefiorini E; Pozzilli C; Bagnato F
Mult Scler; 2007 Apr; 13(3):343-7. PubMed ID: 17439903
[TBL] [Abstract][Full Text] [Related]
11. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
12. [High doses of interferon in the treatment of multiple sclerosis].
Muñoz D
Rev Neurol; 2001 May 1-15; 32(9):899. PubMed ID: 11424041
[No Abstract] [Full Text] [Related]
13. [Diagnostics and drug therapy of multiple sclerosis].
Suomen Neurologinen Yhdistys ry
Duodecim; 2002; 118(13):1411-23. PubMed ID: 12239889
[No Abstract] [Full Text] [Related]
14. [Drug therapy of multiple sclerosis].
Kinnunen E
Duodecim; 1999; 115(4):403-7. PubMed ID: 11830889
[No Abstract] [Full Text] [Related]
15. Gadolinium dose optimisation in patients with multiple sclerosis: intra- and inter-individual comparisons.
Stecco A; Migazzo E; Saponaro A; Scarabino T; Tesser F; Monaco F; Carriero A
Eur J Radiol; 2006 Jan; 57(1):37-42. PubMed ID: 16040220
[TBL] [Abstract][Full Text] [Related]
16. 'Time is brain' also in multiple sclerosis.
Freedman MS
Mult Scler; 2009 Oct; 15(10):1133-4. PubMed ID: 19808740
[No Abstract] [Full Text] [Related]
17. [New therapeutic methods in the treatment of multiple sclerosis].
Nervenarzt; 1996 Nov; 67(11 Suppl Neue Ther):1-12. PubMed ID: 9402424
[No Abstract] [Full Text] [Related]
18. Patient and family fact sheet. Current treatments for multiple sclerosis.
Kernich CA
Neurologist; 2005 Mar; 11(2):137-8. PubMed ID: 15733335
[No Abstract] [Full Text] [Related]
19. Seizure after gadolinium administration.
Hailemeskal B; Ilogu E; Khuc K; Curry C; Kelvas M
Radiol Technol; 1999; 70(4):387. PubMed ID: 10101755
[No Abstract] [Full Text] [Related]
20. Anaphylaxis to gadolinium radiocontrast: a case report and review of the literature.
Shepherd M; Lata S; Mani S; Fiorillo A; Kumar P
J La State Med Soc; 2009; 161(5):282-4. PubMed ID: 19927942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
